Oreste
Gualillo

Foto de Oreste

Foto de Instituto de Investigación Sanitaria La Fe

Instituto de Investigación Sanitaria La Fe

Valencia, España

Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria La Fe (6)

2024

Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue
Biochemical Pharmacology, Vol. 223

2023

The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats
Biomedicine and Pharmacotherapy, Vol. 161

2022

Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases
Journal of Personalized Medicine, Vol. 12, Núm. 7

2021

Relaxin has beneficial effects on liver lipidome and metabolic enzymes
FASEB Journal, Vol. 35, Núm. 7

2019

Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue
Pharmacological Research, Vol. 144, pp. 51-65

2018

Relaxin activates AMPK-AKT signaling and increases glucose uptake by cultured cardiomyocytes
Endocrine, Vol. 60, Núm. 1, pp. 103-111

Proxecto CRIS desenvolto en colaboración coa Fundación Dialnet (Universidad de La Rioja)